Zynex Medical Electrotherapy Pain Management and Growth Strategy slide image

Zynex Medical Electrotherapy Pain Management and Growth Strategy

Zynex Medical Overview Background • • NASDAQ:ZYXI (Listed 2019) Included in Russell 2000 (2019) Listed on OTCQB from 2004-2018 • Included in S&P SmallCap 600 (2020) • • Founded By Thomas Sandgaard – CEO and Chairman . Medical Device Manufacturer - 25 Years • HQ - Englewood, Colorado Business Units • ZYNEX MEDICAL (ZMI) Non-invasive electrotherapy pain management devices "TENS" (>90% of billings¹) • • • 76% gross profit margin¹ Greater than 75% recurring revenue base¹ - supplies (electrodes/batteries) and leased devices Rx required, insurance billed ZYNEX NEURODIAGNOSTICS (ZND) EEG, EMG diagnostics B:B products (<2% of historical billings) NeuroMove Stroke Rehab product • ZYNEX MONITORING SOLUTIONS (ZMS) FDA-cleared, non-invasive blood volume monitor (Zero revenue) 1) Based on Q1 2021 results ZYNEX 5 MEDICAL"
View entire presentation